Gabelli Funds’s Audentes Therapeutics, Inc BOLD Stock Holding History

Gabelli Funds’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-742,692	Closed	-$44.4M	–	1151
2019 Q4	$44.4M	Buy	+742,692	New	+$27.9M	0.29%	100

Gabelli Funds's BOLD Position: Q1 2020 in Review

Gabelli Funds sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 742,692 shares — an estimated $44.4M sold.

Gabelli Funds first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $44.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Gabelli Funds reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Gabelli Funds sold 742,692 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $44.4M.
Gabelli Funds first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Gabelli Funds's Audentes Therapeutics, Inc position peaked at $44.4M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Gabelli Funds's 13F filing for Q1 2020, filed 14 May 2020.